0 NYSE Companies - January 28, 2025QXO Comments on Beacon Roofing Supply’s Adoption of Shareholder-Unfriendly Poison PillReaffirms Commitment to Acquiring Beacon for $124.25 per Share in Cash All-Cash Offer Provides Significant and Immediate Value to Beacon […]Read More
0 NYSE Companies - January 28, 2025High Roller Technologies Partners with Golden Whale to Revolutionize Data-Driven Retention and Acquisition StrategiesCompany to Leverage Golden Whale’s Predictive AI Models and Machine Learning Solution Las Vegas, Nevada, Jan. 28, 2025 (GLOBE NEWSWIRE) […]Read More
0 NYSE Companies - January 28, 2025FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGYMINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), provides a brief shareholder letter from Seamus […]Read More
0 TSX Venture News - January 28, 2025Skyharbour and JV Partner Orano Announces Extensive Exploration and Drilling Program in 2025 at Preston Uranium ProjectVancouver, BC, Jan. 28, 2025 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is […]Read More
0 NYSE Companies - January 28, 2025Stantec to release fourth quarter and full-year 2024 results and host conference call on February 25, 2025EDMONTON, Alberta, Jan. 28, 2025 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec, a global leader in sustainable design and engineering, will […]Read More
0 NYSE Companies - January 28, 2025AgEagle Aerial Systems Completes Successful Exhibition of eBee VISION for Key U.S. Department of Defense Officials DOD Conducts Testing and Evaluation of the AgEagle eBee VISION ISR UAS Platform WICHITA, Kan., Jan. 28, 2025 (GLOBE NEWSWIRE) […]Read More
0 NYSE Companies - January 28, 2025Sysco Reports Second Quarter Fiscal Year 2025 ResultsHOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for […]Read More
0 NYSE Companies - January 28, 2025Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase AgreementSAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing […]Read More